...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>P & T: a peer-reviewed journal for formulary management >Doing more with less?: past and present challenges for the FDA.
【24h】

Doing more with less?: past and present challenges for the FDA.

机译：用更少的钱做更多的事情？：FDA过去和现在的挑战。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

As 2011 dawned, Margaret Hamburg, MD, Commissioner of the FDA, was confronted by several brand-new challenges. On January 2, the incoming chairman of the House Committee on Oversight and Government Reform, Darrell Issa (R-Calif.), announced his intention to launch an investigation of the FDA, which he had described as a "broken bureaucracy." A few days later, the FDA's principal deputy commissioner and former acting commissioner, Joshua Sharfstein, MD, resigned after 21 months of service to become Maryland's secretary of health and mental hygiene. At the same time, the 112th session of Congress convened, with the Senate still under Democratic control but with Republicans then holding a majority in the House. The Republicans were eager to pursue their avowed agenda of reducing the size of government and slashing federal spending, a portent of difficult times ahead for the FDA and every other agency.
机译：随着2011年的到来，FDA专员玛格丽特·汉堡医学博士面临几个全新的挑战。 1月2日，即将上任的内务监督与政府改革委员会主席达雷尔·伊萨（R-Calif。）宣布打算对FDA进行调查，他称这是“官僚作风的破灭”。几天后，FDA的首席副专员兼前代理专员约书亚·沙夫斯坦（Joshua Sharfstein）辞职21个月后辞职，成为马里兰州的健康和精神卫生部长。同时，国会第112届会议召开，参议院仍由民主党控制，但共和党则在众议院占多数。共和党人渴望遵循其公开的议程，以缩小政府规模并削减联邦支出，这对于FDA和其他机构来说都是艰难时期的预兆。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号